Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Key Sessions

Dean Pettit, Ph.D.

Improving Global Access to Biotherapeutics through Molecule, Process and Manufacturing Design

Just Biotherapeutics

Flemming Ornskov, M.D., M.P.H.

Presentation Title TBA


James Collins, Ph.D.

Synthetic Biology: Biomedical Applications Come of Age

Massachusetts Institute of Technology

3:00pm 5:30pm (150 mins)

Main agenda

Startup Pitch Competition @ Biopharm America

Pitch your startup to a panel of judges comprised of business development execs, venture capitalists, and industry experts! 

Qualifying startup companies are invited to pitch their company using no more than four minutes. Our top notch panel of judges will determine the winner by the quality and effectiveness of the pitch.

  • Moderator Douglas MacDougall - President, MacDougall Biomedical Communications
  • Judge Christine Brennan - Principal, Novartis Venture Fund
  • Judge Jeremy Springhorn - Partner, Corporate Development, Flagship Ventures
  • Judge Anna Turetsky - Associate, Lightstone Ventures
  • Judge Geeta Vemuri - Managing Partner, Agent Capital
  • Judge Charles Kunsch - Director, AbbVie Ventures

3:15pm 3:45pm (30 mins)

Main agenda

Grand Opening of the BWB Exhibit & Poster Hall and Refreshment Break

3:40pm 3:45pm (5 mins)

Main agenda

Chairperson’s Remarks

3:45pm 4:15pm (30 mins)

Main agenda

Improving Global Access to Biotherapeutics through Molecule, Process and Manufacturing Design

This presentation will discuss the application of innovative technologies designed to expand global access to biotherapeutics. These integrated technologies will assist biotherapeutic discovery through the application of molecular design tools to improve candidate molecule developability, improve process design through intensification efforts, and reduce fixed costs associated with manufacturing facility construction and operation through the design of facilities with flexible, low cost features.

  • Keynote Dean Pettit, Ph.D. - Chief Scientific Officer and Founding Partner, Just Biotherapeutics

4:15pm 4:45pm (30 mins)

Main agenda

Presentation Title TBA

  • Flemming Ornskov, M.D., M.P.H. - Chief Executive Officer, Shire

4:45pm 5:15pm (30 mins)

Main agenda

Synthetic Biology: Biomedical Applications Come of Age

Synthetic biology is bringing together engineers, physicists and biologists to model, design and construct biological circuits out of proteins, genes and other bits of DNA, and to use these circuits to rewire and reprogram organisms. These re-engineered organisms are going to change our lives in the coming years, leading to cheaper drugs, rapid diagnostic tests, and synthetic probiotics to treat infections and a range of complex diseases. In this talk, we highlight recent efforts to create synthetic gene networks and programmable cells, and discuss a variety of synthetic biology applications in biotechnology and biomedicine.

  • James Collins, Ph.D. - Termeer Professor of Medical Engineering & Science and Professor, Department of Biological Engineering, Massachusetts Institute of Technology

5:15pm 7:00pm (105 mins)

Main agenda

Opening Night "Celebration of Science" Reception in the BWB Exhibit & Poster Hall

7:00pm 10:00pm (180 mins)

Awards and Dinners

Xconomy Awards Gala